Transcatheter Heart Valve Market: Size, Growth, Regional Analysis, And Market Analysis
Transcatheter Heart Valve Implantation: Transcatheter heart valve implantation is a minimally invasive surgery that involves replacing damaged heart valves with bioprosthetic valves to treat valvular heart diseases, such as aortic stenosis and mitral regurgitation. It's a less invasive alternative to open-heart surgery, and it's especially beneficial for people who are at extremely high risk. Market Analysis: By 2024, the Transcatheter Heart Valve Market is expected to reach $6.60 billion, with a CAGR of 13.40 per cent. The rising desire for less intrusive procedures for high-risk patients, as well as the rising prevalence of mitral regurgitation and severe aortic stenosis condition, are driving the transcatheter heart valve replacement and repair market. Transcatheter heart valve devices are also being adopted due to quicker recovery times, shorter hospital stays, good outcomes with transcatheter prosthetic valve implantation, and technological developments. However, the hig